
Schrödinger, Inc.
SDGRNASDAQTechnologySoftware - Application
Previous close
$19.71
+$0.13 · +0.66%
SDGR company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Hold
Wait — insufficient conviction to act
Valuation
47
Fair Value
Momentum
54
Neutral
Sentiment
51
Mixed
Risk resilience
39
High Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteSchrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
- Industry
- Software - Application
- Sector
- Technology
- Headquarters
- US
- CEO
- Ramy Farid
- Listed since
- Feb 5, 2020
- Employees
- 850
Market position
Day range
Current $19.71
52-week range
Current $19.71
- Open
- $19.825
- Previous close
- $19.58
- Volume
- 1.1M
- 0.81× average
- Average volume
- 1.35M
- Average daily volume
- Market cap
- 1.47B USD
- Beta
- 1.66
- Market reference 1
- 50-day average
- $16.3798
- +20.33% above average
- 200-day average
- $15.0158
- +31.26% above average
Financials
Financial snapshot
Latest / TTMValuation & yield
- P/E (TTM)
- -26.64×
- P/B (TTM)
- 4.48×
- P/S (TTM)
- 5.69×
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 56.87%
- Operating margin
- -59.24%
- Net margin
- -20.98%
Financial health
- Debt / equity
- 0.33×
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 255.87M USD | 207.54M USD | 216.67M USD | 180.96M USD | 137.93M USD |
| Cost of goods sold | 113.26M USD | 75.46M USD | 75.97M USD | 79.93M USD | 72.31M USD |
| Gross profit | 142.61M USD | 132.08M USD | 140.69M USD | 101.02M USD | 65.62M USD |
| Research and development | 173.14M USD | 201.79M USD | 181.77M USD | 126.37M USD | 90.9M USD |
| Selling, general, and administrative | 136.37M USD | 139.59M USD | 136.37M USD | 121.47M USD | 86.16M USD |
| Operating expenses | 309.51M USD | 341.38M USD | 318.14M USD | 247.84M USD | 177.06M USD |
| Interest income | — | — | — | 3.95M USD | 1.06M USD |
| Interest expense | — | — | — | 3K USD | — |
| Depreciation and amortization | 6.02M USD | 6.16M USD | 5.55M USD | 4.34M USD | 2.85M USD |
| Operating income | −166.9M USD | −209.3M USD | −177.45M USD | −146.82M USD | −111.44M USD |
| Net income | −103.27M USD | −187.12M USD | 40.72M USD | −149.19M USD | −100.39M USD |
Company facts updated Aug 24, 2026.
Analyst ratings
Third-party consensus; not a GoAI recommendation.
Rating distribution
12 ratingsSDGR peers
ETFs holding SDGR
Funds reporting this stock among their holdings, ordered by reported position size.
iShares Core S&P Small-Cap ETFIJR60.42M0.05%111.19B USD0.06%$147.31+0.64%
ARK Genomic Revolution ETFARKG42.38M2.23%1.56B USD0.75%$49.45+3.80%
Vanguard Morningstar Total Stock Market ETFVTI29.75M0.00%2.3T USD0.03%$378.24+0.44%
iShares Russell 2000 ETFIWM28.65M0.04%81.62B USD0.19%$299.96+0.77%
Vanguard Morningstar Small-Cap ETFVB21.76M0.01%183.4B USD0.03%$304.76+0.64%
Vanguard Morningstar Small-Cap Growth ETFVBK12.59M0.03%43.8B USD0.05%$358.65+0.70%
iShares Russell 2000 Growth ETFIWO10.65M0.07%15.16B USD0.24%$387.37+1.24%
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM10.41M0.06%17.03B USD0.03%$57.28+0.61%
iShares Core S&P Small-Cap ETFIJR- Market value
- 60.42M
- Weight
- 0.05%
- AUM
- 111.19B USD
- Expense ratio
- 0.06%
- Price / 1D
- $147.31+0.64%
ARK Genomic Revolution ETFARKG- Market value
- 42.38M
- Weight
- 2.23%
- AUM
- 1.56B USD
- Expense ratio
- 0.75%
- Price / 1D
- $49.45+3.80%
Vanguard Morningstar Total Stock Market ETFVTI- Market value
- 29.75M
- Weight
- 0.00%
- AUM
- 2.3T USD
- Expense ratio
- 0.03%
- Price / 1D
- $378.24+0.44%
iShares Russell 2000 ETFIWM- Market value
- 28.65M
- Weight
- 0.04%
- AUM
- 81.62B USD
- Expense ratio
- 0.19%
- Price / 1D
- $299.96+0.77%
Vanguard Morningstar Small-Cap ETFVB- Market value
- 21.76M
- Weight
- 0.01%
- AUM
- 183.4B USD
- Expense ratio
- 0.03%
- Price / 1D
- $304.76+0.64%
Vanguard Morningstar Small-Cap Growth ETFVBK- Market value
- 12.59M
- Weight
- 0.03%
- AUM
- 43.8B USD
- Expense ratio
- 0.05%
- Price / 1D
- $358.65+0.70%
iShares Russell 2000 Growth ETFIWO- Market value
- 10.65M
- Weight
- 0.07%
- AUM
- 15.16B USD
- Expense ratio
- 0.24%
- Price / 1D
- $387.37+1.24%
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM- Market value
- 10.41M
- Weight
- 0.06%
- AUM
- 17.03B USD
- Expense ratio
- 0.03%
- Price / 1D
- $57.28+0.61%
Continue in GoAI
Research SDGRresearch.disclaimer





